Drugs in Context Respiratory welcomes a broad range of article types including original research, study protocols and review articles.
In line with the principle of providing context for healthcare professionals (HCPs) to properly inform and improve disease management in real world medicine, we especially encourage the submission of articles that provide context for trials of drug interventions in order to motivate improvements in disease management by HCPs practising medicine in the front line.
Review
This article reviews the biology, clinicopathological characteristics, targeted therapies and mechanisms of resistance of advanced non-small-cell lung cancer harbouring RET fusions to provide treatment guidance for these patients.
Original Research
This article aims to describe real-world inhaled nitric oxide use and outcomes in patients with COVID-19 with mild-to-moderate acute respiratory distress syndrome in the United States.
Review
This article discusses an update to the ANIBAL protocol in light of the COVID-19 pandemic.
Review
Original Research
This article discussese the effectiveness of Oscillococcinum® in the protection from upper respiratory tract infections in patients with chronic obstructive pulmonary disease who had been vaccinated against influenza infection over the 2018–2019 winter season.
